Christopher A. Evans, PhD, is a dynamic leader with over 19 years of experience in the pharmaceutical industry, currently serving as Vice President and Global Head of Translational Sciences at Galapagos. Previously, from 2020 to 2025, they held a similar position at Adaptimmune, focusing on TCR-T cell therapies. Dr. Evans is recognized as an expert in biomarker analysis and translational research, having led numerous high-performance teams and driven impactful strategies throughout their career. They earned a Doctor of Philosophy in Chemistry from Purdue University and a Bachelor of Science in Chemistry with Honors from the University of Maryland.
Location
Philadelphia, United States
Links
This person is not in the org chart
This person is not in any teams
This person is not in any offices